Breast-feeding and Transmission of HIV-1
- PMID: 14722454
- PMCID: PMC3382106
- DOI: 10.1097/00126334-200402010-00015
Breast-feeding and Transmission of HIV-1
Erratum in
- J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):539
Abstract
Breast-feeding substantially increases the risk of HIV-1 transmission from mother to child, and although peripartum antiretroviral therapy prophylaxis significantly decreases the risk of mother-to-child transmission around the time of delivery, this approach does not affect breast-feeding transmission. Increased maternal RNA viral load in plasma and breast milk is strongly associated with increased risk of transmission through breast-feeding, as is breast health, and it has been suggested that exclusive breast-feeding could be associated with lower rates of breast-feeding transmission than mixed feeding of both breast- and other milk or feeds. Transmission through breast-feeding can take place at any point during lactation, and the cumulative probability of acquisition of infection increases with duration of breast-feeding. HIV-1 has been detected in breast milk in cell-free and cellular compartments; infant gut mucosal surfaces are the most likely site at which transmission occurs. Innate and acquired immune factors may act most effectively in combination to prevent primary HIV-1 infection by breast milk.
References
-
- Nduati R, John G, Ngacha DA, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomised clinical trial. JAMA. 2000;283:1167–1174. - PubMed
-
- Leroy V, Karon JM, Alioum A, et al. 24-month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS. 2002;16:631–641. - PubMed
-
- Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet. 1999;353:773–780. - PubMed
-
- Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d’Ivoire: a randomised trial. Lancet. 1999;353:781–785. - PubMed
-
- Dabis F, Msellati P, Meda N, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d’Ivoire and Burkina Faso: a double-blind placebo controlled multicentre trial. Lancet. 1999;353:786–792. - PubMed
